Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution Executive VP and CMO Marco Cardazzi Buys $25.1K of Stock

Marco Cardazzi, Executive VP and CMO, bought 2,508 shares of Adi Global Distribution Inc. at $10.00 a share, worth $25.1K in total on Nov 13, 2026. Shares held after the trade: 12,917 (+24.1%).

Value
$25.1K
Shares
2,508
Price
$10.00
Role
Executive VP and CMO
Holding change
+24.1%
Trade date
Nov 13, 2026
6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution President and CEO Robert B. Aarnes Buys $100K of Stock

Robert B. Aarnes, President and CEO, bought 10,073 shares of Adi Global Distribution Inc. at $9.93 a share, worth $100K in total on Nov 13, 2026. Shares held after the trade: 123,721 (+8.9%).

Value
$100K
Shares
10,073
Price
$9.93
Role
President and CEO
Holding change
+8.9%
Trade date
Nov 13, 2026
6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution Exec. VP, GC, Corp. Sec. & CCO Jeannine J. Lane Buys $50.1K of Stock

Jeannine J. Lane, Exec. VP, GC, Corp. Sec. & CCO, bought 5,241 shares of Adi Global Distribution Inc. at $9.55 a share, worth $50.1K in total on Nov 16, 2026. Shares held after the trade: 86,133 (+6.5%).

Value
$50.1K
Shares
5,241
Price
$9.55
Role
Exec. VP, GC, Corp. Sec. & CCO
Holding change
+6.5%
Trade date
Nov 16, 2026
6:32 PM ET Form 4
Insider Buying Adi Global Distribution Inc. ADIG

Adi Global Distribution Executive VP, CFO Michael Carlet Buys $99.9K of Stock

Michael Carlet, Executive VP, CFO, bought 10,288 shares of Adi Global Distribution Inc. at $9.71 a share, worth $99.9K in total on Nov 13, 2026. Shares held after the trade: 50,623 (+25.5%).

Value
$99.9K
Shares
10,288
Price
$9.71
Role
Executive VP, CFO
Holding change
+25.5%
Trade date
Nov 13, 2026
6:32 PM ET Form 4
Insider Selling Covenant Logistics Group, Inc. CVLG

Covenant Logistics Group Chairman and CEO David Ray Parker Sells $5.66M of Stock

David Ray Parker, Chairman and CEO, sold 173,989 shares of Covenant Logistics Group, Inc. at $32.35 to $33.77 a share (average $32.54) in 4 transactions, worth $5.66M in total between Nov 12, 2026 and Nov 16, 2026. Shares held after the trade: 1,803,555 (-4.7%).

Value
$5.66M
Shares
173,989
Average price
$32.54
Role
Chairman and CEO
Holding change
-4.7%
Trade date
Nov 12, 2026 to Nov 16, 2026
6:32 PM ET 10-Q
Financial Results SDR Drone, Inc.

SDR Drone Q3 2026 Results: Net Loss of $182K, Loss Narrows

SDR Drone, Inc. reported a net loss of $598,438 for the nine months ended September 30, 2026, compared to a loss of $760,649 in the prior year period. The company remains in a development stage with zero revenue and a stockholders' deficit of $243,944, primarily driven by professional fees and non-cash expenses related to debt amortization and derivative liabilities.

Key figure
Net loss $182K
6:32 PM ET 10-Q
Financial Results ConnectM Technology Solutions, Inc.

ConnectM Technology Solutions Q3 2026 Results: Net Loss of $8.12M, Loss Widens

For the nine months ended September 30, 2026, ConnectM Technology Solutions reported revenues of $26.35 million, an increase from $24.31 million in the prior year. The company recorded a net loss attributable to stockholders of $2.32 million, significantly improved from a $12.18 million loss in 2025, primarily due to a $19.05 million gain on the disposal of discontinued operations.

Key figure
Net loss $8.12M
6:32 PM ET 10-Q
Financial Results Host Digital Inc. HOST

Host Digital Q3 2026 Results: Net Loss of $9.67M

Host Digital Inc. reported a net loss of $11.45 million for the eight months ended September 30, 2026, following a reverse acquisition and public offering in September 2026. The company generated $1.48 million in net sales during the period, while significantly expanding its balance sheet to $108.2 million in total assets, primarily through intangible assets and right-of-use assets.

Key figure
Net loss $9.67M
6:32 PM ET 10-Q
Financial Results Picard Medical, Inc. PMI

Picard Medical Q3 2026 Results: Net Loss of $2.22M, Loss Narrows

Picard Medical, Inc. is a newly public medical device company focused on total artificial heart therapy, reporting 2,661,574 shares outstanding as of November 12, 2026. The filing highlights significant risks including customer concentration, reliance on single-source suppliers, and an explanatory paragraph from its auditors regarding its ability to continue as a going concern.

Key figure
Net loss $2.22M
6:32 PM ET 10-Q
Financial Results Cyabra, Inc. CYAB

Cyabra Q3 2026 Results: Net Loss of $2.59M, Loss Narrows

Cyabra, Inc. reported revenues of $5.27 million for the nine months ended September 30, 2026, compared to $4.08 million in the prior year period. The company experienced a significant net loss of $16.8 million, driven by increased research and development and general administrative expenses following a business combination and PIPE financing.

Key figure
Net loss $2.59M
4:58 PM ET Form 4
Insider Buying Corteva, Inc. CTVA

Corteva Director Gregory R. Page Buys $185K of Stock

Gregory R. Page, Director, bought 20,000 shares of Corteva, Inc. at $9.25 to $9.29 a share (average $9.27) in 2 transactions, worth $185K in total between Nov 13, 2026 and Nov 16, 2026. Shares held after the trade: 20,000 (+100.0%).

Value
$185K
Shares
20,000
Average price
$9.27
Role
Director
Holding change
+100.0%
Trade date
Nov 13, 2026 to Nov 16, 2026
4:58 PM ET Form 4
Insider Selling Thermo Fisher Scientific Inc. TMO

Thermo Fisher Scientific President & COO Gianluca Pettiti Sells $2.9M of Stock

Gianluca Pettiti, President & COO, sold 4,133 shares of Thermo Fisher Scientific Inc. at $701.42 a share, worth $2.9M in total on Nov 13, 2026. Shares held after the trade: 22,816 (-14.1%).

Value
$2.9M
Shares
4,133
Average price
$701.42
Role
President & COO
Holding change
-14.1%
Trade date
Nov 13, 2026
4:58 PM ET Form 4
Insider Selling Equinix Inc EQIX

Equinix CLO Kurt Pletcher Sells $141K of Stock

Kurt Pletcher, CLO, sold 135 shares of Equinix Inc at $1,041.36 a share, worth $141K in total on Nov 16, 2026. Shares held after the trade: 3,744 (-3.5%).

Value
$141K
Shares
135
Price
$1,041.36
Role
CLO
Holding change
-3.5%
Trade date
Nov 16, 2026
4:58 PM ET Form 4
Insider Buying Orion180 Insurance Group Inc. OIG

Orion180 Insurance Group CEO Kenneth Gregg Buys $1.02M of Stock

Kenneth Gregg, CEO, bought 96,150 shares of Orion180 Insurance Group Inc. at $10.66 a share, worth $1.02M in total on Nov 12, 2026. Shares held after the trade: 60,031,410 (+0.2%).

Value
$1.02M
Shares
96,150
Price
$10.66
Role
CEO
Holding change
+0.2%
Trade date
Nov 12, 2026
4:51 PM ET Form 4
Insider Buying Global Self Storage, Inc. SELF

Global Self Storage Chairman and CEO Mark Campbell Winmill Buys $29.1K of Stock

Mark Campbell Winmill, Chairman and CEO, bought 5,947 shares of Global Self Storage, Inc. at $4.90 a share, worth $29.1K in total on Nov 13, 2026. Shares held after the trade: 379,082 (+0.9%).

Value
$29.1K
Shares
5,947
Average price
$4.90
Role
Chairman and CEO
Holding change
+0.9%
Trade date
Nov 13, 2026
4:51 PM ET Form 4
Insider Buying Corteva, Inc. CTVA

Corteva CEO Luther C. Kissam IV Buys $300K of Stock

Luther C. Kissam IV, CEO, bought 32,292 shares of Corteva, Inc. at $9.30 a share, worth $300K in total on Nov 13, 2026. Shares held after the trade: 185,379 (+21.1%).

Value
$300K
Shares
32,292
Price
$9.30
Role
CEO
Holding change
+21.1%
Trade date
Nov 13, 2026
4:51 PM ET Form 4
Insider Buying Lightpath Technologies Inc LPTH

Lightpath Technologies President & CEO Shmuel Rubin Buys $19.2K of Stock

Shmuel Rubin, President & CEO, bought 2,860 shares of Lightpath Technologies Inc at $6.71 a share, worth $19.2K in total on Nov 13, 2026. Shares held after the trade: 286,073 (+1.0%).

Value
$19.2K
Shares
2,860
Price
$6.71
Role
President & CEO
Holding change
+1.0%
Trade date
Nov 13, 2026
4:47 PM ET 10-Q
Financial Results NovelStem International Corp.

NovelStem International Q3 2026 Results: Net Loss of $84.3K, Loss Widens

NovelStem International Corp. reported a net loss of $225,105 for the nine months ended September 30, 2026, compared to a net income of $2,469,177 in the prior year period which was driven by one-time debt relief and investment disposal gains. The company continues to operate with a significant shareholders' deficit of $2.1 million and requires additional financing to sustain operations following the liquidation of its primary equity investment, NewStem.

Key figure
Net loss $84.3K
4:47 PM ET 10-Q
Financial Results ASP Isotopes Inc. ASPI

ASP Isotopes Q3 2026 Results: Net Loss of $30.9M, Loss Widens

The filing highlights significant volatility in natural gas and helium markets, noting that Henry Hub spot prices fluctuated between $2.54 and $30.72 per MMBtu in early 2026. Renergen faces substantial liquidity risks related to its debt covenants and capital expenditure requirements for Phase 2 expansion, while global helium supply remains constrained with spot prices exceeding $2,000/Mcf due to geopolitical disruptions.

Key figure
Net loss $30.9M
4:47 PM ET 10-Q
Financial Results Hydrofarm Holdings Group, Inc. HYFM

Hydrofarm Holdings Group Q3 2026 Results: Net Loss of $7.78M, Loss Narrows

Hydrofarm Holdings Group reported a significant decline in net sales to $14.5 million for the third quarter of 2026 compared to $29.4 million in the prior year, driven by industry oversupply and customer pricing pressures. The company recorded a net loss for the nine-month period of $33.0 million and reported a total stockholders' deficit of $93.9 million, raising concerns about its ability to continue as a going concern.

Key figure
Net loss $7.78M
4:46 PM ET 8-K
Clinical Trial Data iBio, Inc. IBIO

iBio Clinical Trial Data

iBio announced extended preclinical data from a non-human primate study of IBIO-610, showing a 2.3% reduction in body weight and significant fat mass reduction over 28 weeks while maintaining lean mass. The company also disclosed preclinical data for its amylin program demonstrating selective receptor activation and reduced food intake in rat models. These results highlight the efficacy of iBio's AI-enabled antibody discovery platform in targeting obesity and cardiometabolic diseases.

4:46 PM ET 8-K
Financial Results Traws Pharma, Inc. TRAW

Traws Pharma Financial Results

Traws Pharma reported Q3 2026 financial results and provided clinical updates for its COVID-19 and influenza antiviral programs. The company highlighted positive Phase 2a results for ratutrelvir and plans to engage the FDA on a registration strategy for PAXLOVID-ineligible patients.

Term
Q3 2026

“We have made meaningful progress toward our goal of developing new treatment and prevention options for patients most vulnerable to serious respiratory viral diseases.”

Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma

“For tivoxavir marboxil, the tablet bridging study achieved its objectives, and toxicology retesting is complete. These results support further evaluation of TXM as a potential once-monthly oral influenza prevention option. We expect to resubmit the updated toxicology package in the fourth quarter.”

Iain Dukes, MA, DPhil, Chief Executive Officer of Traws Pharma
4:46 PM ET 8-K
Financial Results Bridger Aerospace Group Holdings, Inc. BAER

Bridger Aerospace Group Holdings Financial Results

Bridger Aerospace reported third quarter 2026 revenue of $56.7 million, a 13% increase compared to the prior year period. The company announced a strategic review of alternatives to refocus on core aerial services and high-margin business lines. Additionally, the company reported a net loss of $1.8 million for the quarter, an improvement from a $13.4 million net loss in Q3 2025.

Term
Q3 2026
4:46 PM ET 8-K
Financial Results Toppoint Holdings Inc. TOPP

Toppoint Holdings Financial Results

Toppoint Holdings reported Q3 2026 revenue of $4.5 million and a net loss of $0.09 million, a significant improvement from the $4.15 million loss in the prior-year period. The company also announced a one-for-five reverse stock split effective November 23, 2026, following a trading halt by NYSE American due to low share price.

Term
Q3 2026
4:46 PM ET 8-K
Reverse Stock Split Arrive AI Inc. ARAI

Arrive AI Reverse Stock Split

Arrive AI Inc. implemented a 1-for-48 reverse stock split of its common stock effective November 12, 2026. The action reduced the number of outstanding shares from approximately 68.8 million to 1.4 million to increase the per-share trading price and regain compliance with Nasdaq's $1.00 minimum bid price requirement.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.